Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum AcquisitionGlobeNewsWire • 08/03/23
Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum PharmaceuticalsGlobeNewsWire • 07/27/23
Assertio Holdings, Inc. to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023GlobeNewsWire • 07/24/23
SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPIBusiness Wire • 06/30/23
Assertio Holdings: Spectrum Pharmaceuticals Has A Merger Spread Plus A Free CVRSeeking Alpha • 06/17/23
Assertio Holdings: Promising Small Cap With Strong Financials And Strategic PlansSeeking Alpha • 06/15/23
ASRT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Assertio Holdings, Inc. Is Fair to ShareholdersBusiness Wire • 06/07/23
Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 OutlookGlobeNewsWire • 05/09/23
Assertio Holdings, Inc. Updates First Quarter 2023 Financial Results Call Time to Tuesday, May 9, 2023 at 11:30 am Eastern TimeGlobeNewsWire • 05/05/23
Assertio Holdings, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023GlobeNewsWire • 04/27/23
Spectrum Pharmaceuticals stock pops after Assertio acquires it at a premiumProactive Investors • 04/25/23